Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Autoimmune and infectious skin diseases that target desmogleins.

Amagai M.

Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(5):524-37. Review.

2.

[Desmoglein, the target molecule in autoimmunity and infection].

Amagai M.

Nihon Rinsho Meneki Gakkai Kaishi. 2006 Oct;29(5):325-33. Review. Japanese.

3.

The molecular logic of pemphigus and impetigo: the desmoglein story.

Amagai M.

Vet Dermatol. 2009 Oct;20(5-6):308-12. doi: 10.1111/j.1365-3164.2009.00831.x. Review.

PMID:
20178466
4.

Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome.

Nagasaka T, Nishifuji K, Ota T, Whittock NV, Amagai M.

J Clin Invest. 2004 Nov;114(10):1484-92.

5.

Pemphigus vulgaris and its active disease mouse model.

Amagai M.

Curr Dir Autoimmun. 2008;10:167-81. doi: 10.1159/000131453. Review.

PMID:
18460885
6.

Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1.

Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR.

Nat Med. 2000 Nov;6(11):1275-7.

PMID:
11062541
7.

Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens.

Adams MJ, Reichel MB, King IA, Marsden MD, Greenwood MD, Thirlwell H, Arnemann J, Buxton RS, Ali RR.

Biochem J. 1998 Jan 1;329 ( Pt 1):165-74.

8.

Interspecies conservation and differential expression of mouse desmoglein gene family.

Mahoney MG, Simpson A, Aho S, Uitto J, Pulkkinen L.

Exp Dermatol. 2002 Apr;11(2):115-25.

PMID:
11994138
9.

Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.

Amagai M, Komai A, Hashimoto T, Shirakata Y, Hashimoto K, Yamada T, Kitajima Y, Ohya K, Iwanami H, Nishikawa T.

Br J Dermatol. 1999 Feb;140(2):351-7.

PMID:
10233237
10.

IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.

Oktarina DA, van der Wier G, Diercks GF, Jonkman MF, Pas HH.

Br J Dermatol. 2011 Sep;165(3):552-62. doi: 10.1111/j.1365-2133.2011.10463.x.

PMID:
21692763
11.

Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.

Nguyen VT, Ndoye A, Bassler KD, Shultz LD, Shields MC, Ruben BS, Webber RJ, Pittelkow MR, Lynch PJ, Grando SA.

Arch Dermatol. 2001 Feb;137(2):193-206.

PMID:
11176692
12.

Autoimmunity against desmosomal cadherins in pemphigus.

Amagai M.

J Dermatol Sci. 1999 Jun;20(2):92-102. Review.

PMID:
10379702
13.

Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies.

Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP.

J Biol Chem. 2006 Mar 17;281(11):7623-34. Epub 2005 Dec 23.

14.

Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.

Mentink LF, de Jong MC, Kloosterhuis GJ, Zuiderveen J, Jonkman MF, Pas HH.

Br J Dermatol. 2007 Apr;156(4):635-41. Epub 2007 Jan 30.

PMID:
17263817
15.

Desmoglein as a target in autoimmunity and infection.

Amagai M.

J Am Acad Dermatol. 2003 Feb;48(2):244-52. Review.

PMID:
12582396
16.
17.

Pemphigus as a paradigm of autoimmunity and cell adhesion.

Amagai M.

Keio J Med. 2002 Sep;51(3):133-9.

18.

Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins.

Sekiguchi M, Futei Y, Fujii Y, Iwasaki T, Nishikawa T, Amagai M.

J Immunol. 2001 Nov 1;167(9):5439-48.

19.

Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.

Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR.

J Clin Invest. 1999 Feb;103(4):461-8.

20.

Targetting of desmoglein 1 in inherited and acquired skin diseases.

Whittock NV, Bower C.

Clin Exp Dermatol. 2003 Jul;28(4):410-5. Review.

PMID:
12823304

Supplemental Content

Support Center